
CJC-1295 (No DAC)
A synthetic analogue of the first 29 amino acids of growth hormone-releasing hormone, modified for resistance to enzymatic degradation.
Used as a reference compound in preclinical studies of growth hormone-releasing hormone receptor signalling and somatotroph function.
Specification
- Molecular formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol
- Sequence
- Tyr-
D- Ala- Asp- Ala- Ile- Phe- Thr- Gln- Ser- Tyr- Arg- Lys- Val- Leu- Ala- Gln- Leu- Ser- Ala- Arg- Lys- Leu- Leu- Gln- Asp- Ile- Leu- Ser- Arg- NH230 residues - Purity
- ≥98% (HPLC)
- Appearance
- White lyophilised powder
- Storage
- Store at -20°C, protected from light and moisture. Stable for 2 years sealed.
Standard specification for this compound. The values measured for each lot are on its certificate of analysis.
| Fill | Price | Unit rate | Current lot | Availability |
|---|---|---|---|---|
| 10 mg | £54.99 | £5.50/mg | — | In stock |
In the literature
Dominikowski A, et al · Frontiers in endocrinology · 2026
PMID 42395176doi:10.3389/fendo.2026.1822475
Renke G, Chinellato L · International journal of molecular sciences · 2026
PMID 42123471doi:10.3390/ijms27093890
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Mavrych V, et al · Frontiers in aging · 2026
PMID 42021992doi:10.3389/fragi.2026.1790247
Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026
PMID 41966639doi:10.1007/s40279-026-02437-0
Research Use Only. Not for human or veterinary use.
These materials are supplied to laboratories and research organisations as reagents. They are not medicines, are not supplied for administration to humans or animals, and must not be resold for those purposes.